Recent News

• 02.12.2026 - Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
• 01.06.2026 - Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026

Recent Filings

• 02.09.2026 - 144 Report of proposed sale of securities
• 02.05.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.21.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.20.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.20.2026 - 144 Report of proposed sale of securities
• 01.15.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.14.2026 - 144 Report of proposed sale of securities
• 01.13.2026 - 144 Report of proposed sale of securities
• 01.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.13.2026 - 4 Statement of changes in beneficial ownership of securities